Nam-Su Lee
Impact in
-
- Cancer, Lipids, and Metabolism
-
- Pancreatic and Hepatic Oncology Research
- Viral-associated cancers and disorders
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 18
- Colorectal Cancer Treatments and Studies 7
- Pancreatic and Hepatic Oncology Research 4
-
- Cancer therapeutics and mechanisms 5
- Retinoids in leukemia and cellular processes 4
- Co-authors
- Jong-Ho Won (34 shared papers)Sang Byung Bae (16 shared papers)Hee-Sook Park (12 shared papers)Sang‐Cheol Lee (15 shared papers)Kyoung Ha Kim (20 shared papers)Chan Kyu Kim (17 shared papers)Sung Kyu Park (14 shared papers)Daesik Hong (9 shared papers)
- Journals
- Cancer Research and Treatment (7 papers)Blood (5 papers)Journal of Clinical Oncology (4 papers)JACC CardioOncology (1 paper)Leukemia Research (1 paper)
- Partner nations
- South KoreaUnited StatesThailand
In The Last Decade
Nam-Su Lee
45 papers receiving 345 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 88
- Oncology 150
- Genetics 47
- Hematology 47
- Pathology and Forensic Medicine 41
Countries citing papers authored by Nam-Su Lee
This map shows the geographic impact of Nam-Su Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nam-Su Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nam-Su Lee more than expected).
Fields of papers citing papers by Nam-Su Lee
This network shows the impact of papers produced by Nam-Su Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nam-Su Lee. The network helps show where Nam-Su Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Nam-Su Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 66 | |
| 2 | 2006 | 36 | |
| 3 | 2015 | 23 | |
| 4 | 2018 | 21 | |
| 5 | 2023 | 17 | |
| 6 | 2008 | 17 | |
| 7 | 2007 | 14 | |
| 8 | Low-dose combinations of LBH589 and TRAIL can overcome TRAIL-resistance in colon cancer cell lines. | 2011 | 14 |
| 9 | 2022 | 12 | |
| 10 | 2007 | 11 | |
| 11 | 2014 | 9 | |
| 12 | 2018 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2012 | 7 | |
| 15 | 2004 | 7 | |
| 16 | 2013 | 7 | |
| 17 | 2020 | 6 | |
| 18 | Taxol induces the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor in murine B-cells by stabilization of granulocyte-macrophage colony-stimulating factor nuclear RNA. | 1994 | 6 |
| 19 | 2007 | 6 | |
| 20 | 2011 | 5 |
About Nam-Su Lee
Nam-Su Lee is a scholar working on Oncology, Molecular Biology, Hematology, Genetics and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 356 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (6 papers), Cancer therapeutics and mechanisms (5 papers), Retinoids in leukemia and cellular processes (4 papers), Multiple Myeloma Research and Treatments (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Cancer Research (88 citations), Oncology (150 citations), Genetics (47 citations), Hematology (47 citations) and Pathology and Forensic Medicine (41 citations). Nam-Su Lee has collaborated with scholars based in South Korea, United States and Thailand. Frequent co-authors include Jong-Ho Won, Sang Byung Bae, Hee-Sook Park, Sang‐Cheol Lee, Kyoung Ha Kim, Chan Kyu Kim, Sung Kyu Park, Daesik Hong, Hyun‐Sik Ahn and Min-Young Lee. Their work appears in journals such as Cancer Research and Treatment, Blood, Journal of Clinical Oncology, JACC CardioOncology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.